Pharmacokinetic Determinants of Cisplatin-Induced Subclinical Kidney Injury in Oncology Patients

PURPOSE: The ability to predict and detect clinical and subclinical nephrotoxicity early in the course of therapy has the potential to improve long-term outcomes in cancer patients receiving cisplatin chemotherapy. Pharmacokinetic parameters could serve as predictors of cisplatin-induced nephrotoxic...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Eur J Clin Pharmacol
Prif Awduron: Ibrahim, Mustafa E., Chang, Cara, Hu, Yichun, Hogan, Susan L., Mercke, Nickie, Gomez, Madeleine, O’Bryant, Cindy L., Bowles, Daniel W., George, Blessy, Wen, Xia, Buckley, Brian, Aleksunes, Lauren, Joy, Melanie S.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2018
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656531/
https://ncbi.nlm.nih.gov/pubmed/30220072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-018-2552-z
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg